What drove the intraday move in APAM.AS stock today?

APAM.AS stock rose after Aperam released Q4 results and commentary on 06 Feb 2026. The firm flagged a 2026 recovery even as 2025 net income fell to €9.00 million. Heavy volume of 657,246 shares amplified the move.

How does Meyka AI view APAM.AS stock right now?

Meyka AI rates APAM.AS at **68.26/100 (Grade B, HOLD)** and projects monthly and quarterly levels near €40.09 and €38.28. These model forecasts imply modest near‑term downside versus the current €41.14 price.

Is Aperam’s dividend sustainable for APAM.AS stock investors?

Aperam pays about €1.85 per share, implying a near 4.98% yield. Dividend sustainability depends on free cash flow and board policy; the company reported positive FCF per share of €4.08 but faces cyclical demand risks.

What key risks should holders of APAM.AS stock watch?

Main risks include weak European demand, persistent import pressure (management noted ~25% import share), margin compression, and limited interest coverage (1.51x). These affect earnings and dividend flexibility.

EU Stocks

APAM.AS Aperam EURONEXT up 14.79% intraday after Q4 results: recovery outlook

ByHuzaifa Zahoor February 6, 2026February 6, 2026

APAM.AS stock jumped 14.79% intraday to €41.14 on 06 Feb 2026 after Aperam released Q4 results and commentary pointing to an improving 2026 outlook. The market moved on a mix of headline figures: a sharp net profit decline to €9.00 million for 2025, yet management flagged higher core earnings ahead. Trading volume hit 657,246 shares versus an average of 161,275, underscoring heavy intraday interest on EURONEXT in Europe.